Free tool
FAERS Monitor: Potassium Chloride 0.22% In Sodium Chloride 0.9% In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019708 or its brand name (Potassium Chloride 0.22% In Sodium Chloride 0.9% In Plastic Container, Potassium Chloride, Sodium Chloride). Reports on generic versions are filed under their own applications.
Reports
26
Serious
13
50% of reports
Hospitalization
10
Death reported
3
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- infusion site pain4
- product label confusion4
- vein disorder4
- discomfort3
- hypokalaemia3
- product name confusion3
- sepsis3
- acute kidney injury2
- death2
- intercepted product selection error2
- product expiration date issue2
- product packaging confusion2
- abdominal pain1
- acidosis hyperchloraemic1
- adverse drug reaction1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2012 | 1 |
| 2013 | 7 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,133 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| product name confusionSignal | 3 | 2232.8 | 769.0 | 4,634 |
| acidosis hyperchloraemic | 1 | 1365.6 | 199.5 | 340 |
| intercepted product selection error | 2 | 1245.8 | 328.6 | 1,396 |
| product expiration date issue | 2 | 1156.8 | 305.2 | 1,297 |
| product packaging confusion | 2 | 667.0 | 176.0 | 747 |
| vein disorderSignal | 4 | 647.2 | 262.6 | 1,974 |
| product label confusionSignal | 4 | 555.6 | 225.5 | 1,694 |
| infusion site painSignal | 4 | 251.2 | 102.0 | 762 |
| hypokalaemiaSignal | 3 | 52.6 | 18.1 | 105 |
| discomfortSignal | 3 | 39.8 | 13.7 | 78 |
| sepsisSignal | 3 | 21.8 | 7.5 | 41 |
| acute kidney injury | 2 | 10.6 | 2.8 | 9 |
| adverse drug reaction | 1 | 9.0 | 1.3 | 1 |
| abdominal pain | 1 | 3.5 | 0.5 | 0 |
| death | 2 | 1.9 | 0.5 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.